Innate Pharma SA Number Of Other Equity Instruments Forfeited In Share-based Payment Arrangement
Innate Pharma SA (IPHYF) reported Number Of Other Equity Instruments Forfeited In Share-based Payment Arrangement of 7767600.00% for the 12-month period ending 2019-12-31, per its 20-F filed 2020-04-24.
Discontinued › Notes › Compensation Related Costs
ifrs-full:NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement · last filed 2020-04-24
| Period end | Number Of Other Equity Instruments Forfeited In Share-based Payment Arrangement 12 month |
|---|---|
| 2019-12-31 | 7767600.00% 20-F · filed 2020-04-24 |
| 2018-12-31 | 5052100.00% 20-F · filed 2020-04-24 |